Pharmacogenomics (PGx) Market Report

Global Pharmacogenomics (PGx) Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • POSTDATE：Apr 27, 2021
  • PAGES：229
  • REPORT CODE：GMM656684
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Pharmacogenomics is the study of the role of the genome in drug response. Its name reflects its combining of pharmacology and genomics. Pharmacogenomics analyzes how the genetic makeup of an individual affects his/her response to drugs.

    The Pharmacogenomics (PGx) is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of XX.0% during the forecast period. The research provides insights for the global Pharmacogenomics (PGx) market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Pharmacogenomics (PGx) industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Global Pharmacogenomics (PGx) Market Segmentations:

    By Players:

    • GeneTech

    • Transgenomic, Inc

    • Affymetrix, Inc

    • Illumina, Inc

    • Genset

    • 23andMe, Inc

    • Pfizer, Inc

    • Abbott Laboratories

    • GeneDx

    • Thermo Fisher Scientific

    • Pathway Genomics

    By Types:

    • Polymerase Chain Reaction (PCR)

    • Microarray

    • Sequencing

    • Other

    By End-User:

    • Cardiovascular Diseases (CVD)

    • Central Nervous System (CNS)

    • Cancer/Oncology

    • Infectious Diseases

    • Other

    By Regions:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Pharmacogenomics (PGx) Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global Pharmacogenomics (PGx) Market Size and Growth Rate of Polymerase Chain Reaction (PCR) from 2014 to 2026

      • 1.3.2 Global Pharmacogenomics (PGx) Market Size and Growth Rate of Microarray from 2014 to 2026

      • 1.3.3 Global Pharmacogenomics (PGx) Market Size and Growth Rate of Sequencing from 2014 to 2026

      • 1.3.4 Global Pharmacogenomics (PGx) Market Size and Growth Rate of Other from 2014 to 2026

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global Pharmacogenomics (PGx) Market Size and Growth Rate of Cardiovascular Diseases (CVD) from 2014 to 2026

      • 1.4.2 Global Pharmacogenomics (PGx) Market Size and Growth Rate of Central Nervous System (CNS) from 2014 to 2026

      • 1.4.3 Global Pharmacogenomics (PGx) Market Size and Growth Rate of Cancer/Oncology from 2014 to 2026

      • 1.4.4 Global Pharmacogenomics (PGx) Market Size and Growth Rate of Infectious Diseases from 2014 to 2026

      • 1.4.5 Global Pharmacogenomics (PGx) Market Size and Growth Rate of Other from 2014 to 2026

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America Pharmacogenomics (PGx) Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.1 United States Pharmacogenomics (PGx) Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.2 Canada Pharmacogenomics (PGx) Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.3 Mexico Pharmacogenomics (PGx) Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Pharmacogenomics (PGx) Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.1 Germany Pharmacogenomics (PGx) Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.2 UK Pharmacogenomics (PGx) Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.3 France Pharmacogenomics (PGx) Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.4 Italy Pharmacogenomics (PGx) Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.5 Nordic Countries Pharmacogenomics (PGx) Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.6 Spain Pharmacogenomics (PGx) Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.7 Belgium Pharmacogenomics (PGx) Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.8 Poland Pharmacogenomics (PGx) Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.9 Russia Pharmacogenomics (PGx) Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.10 Turkey Pharmacogenomics (PGx) Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Pharmacogenomics (PGx) Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.1 China Pharmacogenomics (PGx) Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.2 Japan Pharmacogenomics (PGx) Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.3 Australia and New Zealand Pharmacogenomics (PGx) Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.4 India Pharmacogenomics (PGx) Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.5 ASEAN Countries Pharmacogenomics (PGx) Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.6 South Korea Pharmacogenomics (PGx) Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Latin America, Middle East & Africa Pharmacogenomics (PGx) Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.1 GCC Countries Pharmacogenomics (PGx) Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.2 Brazil Pharmacogenomics (PGx) Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.3 Nigeria Pharmacogenomics (PGx) Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.4 South Africa Pharmacogenomics (PGx) Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.5 Argentina Pharmacogenomics (PGx) Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Pharmacogenomics (PGx) Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Pharmacogenomics (PGx) by Major Types

      • 3.4.1 Pharmacogenomics (PGx) Market Size and Growth Rate of Polymerase Chain Reaction (PCR)

      • 3.4.2 Pharmacogenomics (PGx) Market Size and Growth Rate of Microarray

      • 3.4.3 Pharmacogenomics (PGx) Market Size and Growth Rate of Sequencing

      • 3.4.4 Pharmacogenomics (PGx) Market Size and Growth Rate of Other

    4 Segmentation of Pharmacogenomics (PGx) Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Pharmacogenomics (PGx) by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Pharmacogenomics (PGx) in Cardiovascular Diseases (CVD)

      • 4.4.2 Market Size and Growth Rate of Pharmacogenomics (PGx) in Central Nervous System (CNS)

      • 4.4.3 Market Size and Growth Rate of Pharmacogenomics (PGx) in Cancer/Oncology

      • 4.4.4 Market Size and Growth Rate of Pharmacogenomics (PGx) in Infectious Diseases

      • 4.4.5 Market Size and Growth Rate of Pharmacogenomics (PGx) in Other

    5 Market Analysis by Major Regions

    • 5.1 Global Pharmacogenomics (PGx) Production Analysis by Major Regions

    • 5.2 Global Pharmacogenomics (PGx) Consumption Analysis by Major Regions

    • 5.3 Global Pharmacogenomics (PGx) Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Pharmacogenomics (PGx) Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe Pharmacogenomics (PGx) Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Pharmacogenomics (PGx) Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa Pharmacogenomics (PGx) Production, Import, Consumption and Export Analysis

    6 Product Commodity of Pharmacogenomics (PGx) Market in Major Countries

    • 6.1 Top 5 Export Countries in Pharmacogenomics (PGx) market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in Pharmacogenomics (PGx) market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Pharmacogenomics (PGx) market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Pharmacogenomics (PGx) market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in Pharmacogenomics (PGx) market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Pharmacogenomics (PGx) market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7 North America Pharmacogenomics (PGx) Landscape Analysis

    • 7.1 North America Pharmacogenomics (PGx) Landscape Analysis by Major Types

    • 7.2 North America Pharmacogenomics (PGx) Landscape Analysis by Major End-Users

    • 7.3 North America Pharmacogenomics (PGx) Landscape Analysis by Major Countries

      • 7.3.1 United States Pharmacogenomics (PGx) Market Volume and Growth Rate

      • 7.3.2 Canada Pharmacogenomics (PGx) Market Volume and Growth Rate

      • 7.3.3 Mexico Pharmacogenomics (PGx) Market Volume and Growth Rate

    8 Europe Pharmacogenomics (PGx) Landscape Analysis

    • 8.1 Europe Pharmacogenomics (PGx) Landscape Analysis by Major Types

    • 8.2 Europe Pharmacogenomics (PGx) Landscape Analysis by Major End-Users

    • 8.3 Europe Pharmacogenomics (PGx) Landscape Analysis by Major Countries

      • 8.3.1 Germany Pharmacogenomics (PGx) Market Volume and Growth Rate

      • 8.3.2 UK Pharmacogenomics (PGx) Market Volume and Growth Rate

      • 8.3.3 France Pharmacogenomics (PGx) Market Volume and Growth Rate

      • 8.3.4 Italy Pharmacogenomics (PGx) Market Volume and Growth Rate

      • 8.3.5 Nordic Countries Pharmacogenomics (PGx) Market Volume and Growth Rate

      • 8.3.6 Spain Pharmacogenomics (PGx) Market Volume and Growth Rate

      • 8.3.7 Belgium Pharmacogenomics (PGx) Market Volume and Growth Rate

      • 8.3.8 Poland Pharmacogenomics (PGx) Market Volume and Growth Rate

      • 8.3.9 Russia Pharmacogenomics (PGx) Market Volume and Growth Rate

      • 8.3.10 Turkey Pharmacogenomics (PGx) Market Volume and Growth Rate

    9 Asia Pacific Pharmacogenomics (PGx) Landscape Analysis

    • 9.1 Asia Pacific Pharmacogenomics (PGx) Landscape Analysis by Major Types

    • 9.2 Asia Pacific Pharmacogenomics (PGx) Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific Pharmacogenomics (PGx) Landscape Analysis by Major Countries

      • 9.3.1 China Pharmacogenomics (PGx) Market Volume and Growth Rate

      • 9.3.2 Japan Pharmacogenomics (PGx) Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand Pharmacogenomics (PGx) Market Volume and Growth Rate

      • 9.3.4 India Pharmacogenomics (PGx) Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries Pharmacogenomics (PGx) Market Volume and Growth Rate

      • 9.3.6 South Korea Pharmacogenomics (PGx) Market Volume and Growth Rate

    10 Latin America, Middle East & Africa Pharmacogenomics (PGx) Landscape Analysis

    • 10.1 Latin America, Middle East & Africa Pharmacogenomics (PGx) Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa Pharmacogenomics (PGx) Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa Pharmacogenomics (PGx) Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries Pharmacogenomics (PGx) Market Volume and Growth Rate

      • 10.3.2 Brazil Pharmacogenomics (PGx) Market Volume and Growth Rate

      • 10.3.3 Nigeria Pharmacogenomics (PGx) Market Volume and Growth Rate

      • 10.3.4 South Africa Pharmacogenomics (PGx) Market Volume and Growth Rate 

      • 10.3.5 Argentina Pharmacogenomics (PGx) Market Volume and Growth Rate

    11 Major Players Profile

    • 11.1 GeneTech

      • 11.1.1 GeneTech Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Transgenomic, Inc

      • 11.2.1 Transgenomic, Inc Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Affymetrix, Inc

      • 11.3.1 Affymetrix, Inc Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Illumina, Inc

      • 11.4.1 Illumina, Inc Company Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Genset

      • 11.5.1 Genset Company Profile and Recent Development

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 23andMe, Inc

      • 11.6.1 23andMe, Inc Company Profile and Recent Development

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Pfizer, Inc

      • 11.7.1 Pfizer, Inc Company Profile and Recent Development

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 Abbott Laboratories

      • 11.8.1 Abbott Laboratories Company Profile and Recent Development

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 GeneDx

      • 11.9.1 GeneDx Company Profile and Recent Development

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    • 11.10 Thermo Fisher Scientific

      • 11.10.1 Thermo Fisher Scientific Company Profile and Recent Development

      • 11.10.2 Market Performance

      • 11.10.3 Product and Service Introduction

    • 11.11 Pathway Genomics

      • 11.11.1 Pathway Genomics Company Profile and Recent Development

      • 11.11.2 Market Performance

      • 11.11.3 Product and Service Introduction

    12 Data Source and Research Methodology

    The List of Tables and Figures (Totals 89 Figures and 203 Tables)

    • Figure Product Picture

    • Figure Pharmacogenomics (PGx) Market Size and Growth Rate of Polymerase Chain Reaction (PCR) from 2014 to 2026

    • Figure Pharmacogenomics (PGx) Market Size and Growth Rate of Microarray from 2014 to 2026

    • Figure Pharmacogenomics (PGx) Market Size and Growth Rate of Sequencing from 2014 to 2026

    • Figure Pharmacogenomics (PGx) Market Size and Growth Rate of Other from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Global Pharmacogenomics (PGx) Market Size and Growth Rate of Cardiovascular Diseases (CVD) from 2014 to 2026

    • Figure Global Pharmacogenomics (PGx) Market Size and Growth Rate of Central Nervous System (CNS) from 2014 to 2026

    • Figure Global Pharmacogenomics (PGx) Market Size and Growth Rate of Cancer/Oncology from 2014 to 2026

    • Figure Global Pharmacogenomics (PGx) Market Size and Growth Rate of Infectious Diseases from 2014 to 2026

    • Figure Global Pharmacogenomics (PGx) Market Size and Growth Rate of Other from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure North America Pharmacogenomics (PGx) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure United States Pharmacogenomics (PGx) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Pharmacogenomics (PGx) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Pharmacogenomics (PGx) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Pharmacogenomics (PGx) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Pharmacogenomics (PGx) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure UK Pharmacogenomics (PGx) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure France Pharmacogenomics (PGx) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Pharmacogenomics (PGx) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Pharmacogenomics (PGx) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Pharmacogenomics (PGx) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Pharmacogenomics (PGx) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Pharmacogenomics (PGx) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Pharmacogenomics (PGx) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Pharmacogenomics (PGx) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Pharmacogenomics (PGx) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure China Pharmacogenomics (PGx) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Pharmacogenomics (PGx) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Australia and New Zealand Pharmacogenomics (PGx) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure India Pharmacogenomics (PGx) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Pharmacogenomics (PGx) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Pharmacogenomics (PGx) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Latin America, Middle East & Africa Pharmacogenomics (PGx) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Countries Pharmacogenomics (PGx) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Pharmacogenomics (PGx) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nigeria Pharmacogenomics (PGx) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Pharmacogenomics (PGx) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Pharmacogenomics (PGx) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Pharmacogenomics (PGx) Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Pharmacogenomics (PGx)

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Pharmacogenomics (PGx) by Different Types from 2014 to 2026

    • Table Consumption Share of Pharmacogenomics (PGx) by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Polymerase Chain Reaction (PCR)

    • Figure Market Size and Growth Rate of Microarray

    • Figure Market Size and Growth Rate of Sequencing

    • Figure Market Size and Growth Rate of Other

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Pharmacogenomics (PGx) by Different End-Users from 2014 to 2026

    • Table Consumption Share of Pharmacogenomics (PGx) by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Cardiovascular Diseases (CVD)

    • Figure Market Size and Growth Rate of Central Nervous System (CNS)

    • Figure Market Size and Growth Rate of Cancer/Oncology

    • Figure Market Size and Growth Rate of Infectious Diseases

    • Figure Market Size and Growth Rate of Other

    • Table Global Pharmacogenomics (PGx) Production by Major Regions

    • Table Global Pharmacogenomics (PGx) Production Share by Major Regions

    • Figure Global Pharmacogenomics (PGx) Production Share by Major Regions in 2014

    • Figure Global Pharmacogenomics (PGx) Production Share by Major Regions in 2018

    • Figure Global Pharmacogenomics (PGx) Production Share by Major Regions in 2026

    • Table Global Pharmacogenomics (PGx) Consumption by Major Regions

    • Table Global Pharmacogenomics (PGx) Consumption Share by Major Regions

    • Figure Global Pharmacogenomics (PGx) Consumption Share by Major Regions in 2014

    • Figure Global Pharmacogenomics (PGx) Consumption Share by Major Regions in 2018

    • Figure Global Pharmacogenomics (PGx) Consumption Share by Major Regions in 2026

    • Table North America Pharmacogenomics (PGx) Production, Import, Consumption and Export Analysis

    • Table Europe Pharmacogenomics (PGx) Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Pharmacogenomics (PGx) Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa Pharmacogenomics (PGx) Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Pharmacogenomics (PGx) market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Pharmacogenomics (PGx) market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Pharmacogenomics (PGx) market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Pharmacogenomics (PGx) market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Pharmacogenomics (PGx) Consumption by Types from 2014 to 2026

    • Table North America Pharmacogenomics (PGx) Consumption Share by Types from 2014 to 2026

    • Figure North America Pharmacogenomics (PGx) Consumption Share by Types in 2014

    • Figure North America Pharmacogenomics (PGx) Consumption Share by Types in 2018

    • Figure North America Pharmacogenomics (PGx) Consumption Share by Types in 2026

    • Table North America Pharmacogenomics (PGx) Consumption by End-Users from 2014 to 2026

    • Table North America Pharmacogenomics (PGx) Consumption Share by End-Users from 2014 to 2026

    • Figure North America Pharmacogenomics (PGx) Consumption Share by End-Users in 2014

    • Figure North America Pharmacogenomics (PGx) Consumption Share by End-Users in 2018

    • Figure North America Pharmacogenomics (PGx) Consumption Share by End-Users in 2026

    • Table North America Pharmacogenomics (PGx) Consumption by Major Countries from 2014 to 2026

    • Table North America Pharmacogenomics (PGx) Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Pharmacogenomics (PGx) Consumption Share by Major Countries in 2014

    • Figure North America Pharmacogenomics (PGx) Consumption Share by Major Countries in 2018

    • Figure North America Pharmacogenomics (PGx) Consumption Share by Major Countries in 2026

    • Figure United States Pharmacogenomics (PGx) Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Pharmacogenomics (PGx) Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Pharmacogenomics (PGx) Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Pharmacogenomics (PGx) Consumption by Types from 2014 to 2026

    • Table Europe Pharmacogenomics (PGx) Consumption Share by Types from 2014 to 2026

    • Figure Europe Pharmacogenomics (PGx) Consumption Share by Types in 2014

    • Figure Europe Pharmacogenomics (PGx) Consumption Share by Types in 2018

    • Figure Europe Pharmacogenomics (PGx) Consumption Share by Types in 2026

    • Table Europe Pharmacogenomics (PGx) Consumption by End-Users from 2014 to 2026

    • Table Europe Pharmacogenomics (PGx) Consumption Share by End-Users from 2014 to 2026

    • Figure Europe Pharmacogenomics (PGx) Consumption Share by End-Users in 2014

    • Figure Europe Pharmacogenomics (PGx) Consumption Share by End-Users in 2018

    • Figure Europe Pharmacogenomics (PGx) Consumption Share by End-Users in 2026

    • Table Europe Pharmacogenomics (PGx) Consumption by Major Countries from 2014 to 2026

    • Table Europe Pharmacogenomics (PGx) Consumption Share by Major Countries from 2014 to 2026

    • Figure Europe Pharmacogenomics (PGx) Consumption Share by Major Countries in 2014

    • Figure Europe Pharmacogenomics (PGx) Consumption Share by Major Countries in 2018

    • Figure Europe Pharmacogenomics (PGx) Consumption Share by Major Countries in 2026

    • Figure Germany Pharmacogenomics (PGx) Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Pharmacogenomics (PGx) Market Volume and Growth Rate from 2014 to 2026

    • Figure France Pharmacogenomics (PGx) Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Pharmacogenomics (PGx) Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Pharmacogenomics (PGx) Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Pharmacogenomics (PGx) Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Pharmacogenomics (PGx) Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Pharmacogenomics (PGx) Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Pharmacogenomics (PGx) Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Pharmacogenomics (PGx) Consumption by Types from 2014 to 2026

    • Table Asia Pacific Pharmacogenomics (PGx) Consumption Share by Types from 2014 to 2026

    • Figure Asia Pacific Pharmacogenomics (PGx) Consumption Share by Types in 2014

    • Figure Asia Pacific Pharmacogenomics (PGx) Consumption Share by Types in 2018

    • Figure Asia Pacific Pharmacogenomics (PGx) Consumption Share by Types in 2026

    • Table Asia Pacific Pharmacogenomics (PGx) Consumption by End-Users from 2014 to 2026

    • Table Asia Pacific Pharmacogenomics (PGx) Consumption Share by End-Users from 2014 to 2026

    • Figure Asia Pacific Pharmacogenomics (PGx) Consumption Share by End-Users in 2014

    • Figure Asia Pacific Pharmacogenomics (PGx) Consumption Share by End-Users in 2018

    • Figure Asia Pacific Pharmacogenomics (PGx) Consumption Share by End-Users in 2026

    • Table Asia Pacific Pharmacogenomics (PGx) Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Pharmacogenomics (PGx) Consumption Share by Major Countries from 2014 to 2026

    • Figure Asia Pacific Pharmacogenomics (PGx) Consumption Share by Major Countries in 2014

    • Figure Asia Pacific Pharmacogenomics (PGx) Consumption Share by Major Countries in 2018

    • Figure Asia Pacific Pharmacogenomics (PGx) Consumption Share by Major Countries in 2026

    • Figure China Pharmacogenomics (PGx) Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Pharmacogenomics (PGx) Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia and New ZealandPharmacogenomics (PGx) Market Volume and Growth Rate from 2014 to 2026

    • Figure India Pharmacogenomics (PGx) Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Pharmacogenomics (PGx) Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Pharmacogenomics (PGx) Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Pharmacogenomics (PGx) Consumption by Types from 2014 to 2026

    • Table Latin America, Middle East & Africa Pharmacogenomics (PGx) Consumption Share by Types from 2014 to 2026

    • Figure Latin America, Middle East & Africa Pharmacogenomics (PGx) Consumption Share by Types in 2014

    • Figure Latin America, Middle East & Africa Pharmacogenomics (PGx) Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa Pharmacogenomics (PGx) Consumption Share by Types in 2026

    • Table Latin America, Middle East & Africa Pharmacogenomics (PGx) Consumption by End-Users from 2014 to 2026

    • Table Latin America, Middle East & Africa Pharmacogenomics (PGx) Consumption Share by End-Users from 2014 to 2026

    • Figure Latin America, Middle East & Africa Pharmacogenomics (PGx) Consumption Share by End-Users in 2014

    • Figure Latin America, Middle East & Africa Pharmacogenomics (PGx) Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa Pharmacogenomics (PGx) Consumption Share by End-Users in 2026

    • Table Latin America, Middle East & Africa Pharmacogenomics (PGx) Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Pharmacogenomics (PGx) Consumption Share by Major Countries from 2014 to 2026

    • Figure Latin America, Middle East & Africa Pharmacogenomics (PGx) Consumption Share by Major Countries in 2014

    • Figure Latin America, Middle East & Africa Pharmacogenomics (PGx) Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa Pharmacogenomics (PGx) Consumption Share by Major Countries in 2026

    • Figure GCC Countries Pharmacogenomics (PGx) Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Pharmacogenomics (PGx) Market Volume and Growth Rate from 2014 to 2026

    • Figure Nigeria Pharmacogenomics (PGx) Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Pharmacogenomics (PGx) Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Pharmacogenomics (PGx) Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of GeneTech

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GeneTech

    • Figure Sales and Growth Rate Analysis of GeneTech

    • Figure Revenue and Market Share Analysis of GeneTech

    • Table Product and Service Introduction of GeneTech

    • Table Company Profile and Development Status of Transgenomic, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Transgenomic, Inc

    • Figure Sales and Growth Rate Analysis of Transgenomic, Inc

    • Figure Revenue and Market Share Analysis of Transgenomic, Inc

    • Table Product and Service Introduction of Transgenomic, Inc

    • Table Company Profile and Development Status of Affymetrix, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Affymetrix, Inc

    • Figure Sales and Growth Rate Analysis of Affymetrix, Inc

    • Figure Revenue and Market Share Analysis of Affymetrix, Inc

    • Table Product and Service Introduction of Affymetrix, Inc

    • Table Company Profile and Development Status of Illumina, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Illumina, Inc

    • Figure Sales and Growth Rate Analysis of Illumina, Inc

    • Figure Revenue and Market Share Analysis of Illumina, Inc

    • Table Product and Service Introduction of Illumina, Inc

    • Table Company Profile and Development Status of Genset

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genset

    • Figure Sales and Growth Rate Analysis of Genset

    • Figure Revenue and Market Share Analysis of Genset

    • Table Product and Service Introduction of Genset

    • Table Company Profile and Development Status of 23andMe, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of 23andMe, Inc

    • Figure Sales and Growth Rate Analysis of 23andMe, Inc

    • Figure Revenue and Market Share Analysis of 23andMe, Inc

    • Table Product and Service Introduction of 23andMe, Inc

    • Table Company Profile and Development Status of Pfizer, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer, Inc

    • Figure Sales and Growth Rate Analysis of Pfizer, Inc

    • Figure Revenue and Market Share Analysis of Pfizer, Inc

    • Table Product and Service Introduction of Pfizer, Inc

    • Table Company Profile and Development Status of Abbott Laboratories

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott Laboratories

    • Figure Sales and Growth Rate Analysis of Abbott Laboratories

    • Figure Revenue and Market Share Analysis of Abbott Laboratories

    • Table Product and Service Introduction of Abbott Laboratories

    • Table Company Profile and Development Status of GeneDx

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GeneDx

    • Figure Sales and Growth Rate Analysis of GeneDx

    • Figure Revenue and Market Share Analysis of GeneDx

    • Table Product and Service Introduction of GeneDx

    • Table Company Profile and Development Status of Thermo Fisher Scientific

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Thermo Fisher Scientific

    • Figure Sales and Growth Rate Analysis of Thermo Fisher Scientific

    • Figure Revenue and Market Share Analysis of Thermo Fisher Scientific

    • Table Product and Service Introduction of Thermo Fisher Scientific

    • Table Company Profile and Development Status of Pathway Genomics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pathway Genomics

    • Figure Sales and Growth Rate Analysis of Pathway Genomics

    • Figure Revenue and Market Share Analysis of Pathway Genomics

    • Table Product and Service Introduction of Pathway Genomics


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US